Study types and study issues in clinical medicine

Forensic Science International

Volumn 165, Issue 2-3, 2007, Pages 98-107

  Koller, Michael ^a   Lorenz, Wilfried ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE CONTROL STUDY; CASE REPORT; CLINICAL MEDICINE; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER AIDED DESIGN; CONSENSUS; CONTROLLED CLINICAL TRIAL; DECISION MAKING; ETHICS; EVIDENCE BASED PRACTICE; EXPERT SYSTEM; FORENSIC MEDICINE; HEALTH CARE; MEDICAL RESEARCH; META ANALYSIS; METHODOLOGY; OUTCOMES RESEARCH; PHILOSOPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLICATION; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SCIENCE IN GENERAL;

EID: 33846104481     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2006.05.010     Document Type: Article

References (42)

1. Hill A.B. Statistical Methods in Clinical and Preventive Medicine (1962), E. & S. Livingstone Ltd., Edinburgh, London
2. Hill A.B. The environment and disease: association or causation?. Proceedings of the Royal Society of Medicine, vol. 58 (1965) 295-300
3. Neugebauer E., Rothmund M., Lorenz W., and Konzept. Struktur und Praxis prospektiver klinischer Studien. Chirurg 60 (1989) 203-213
4. Madea B., Dettmeyer R., and Mußhoff F. Aufgaben rechtsmedizinischer Forschung: Differente Studientypen in Grundlagenfächern, Klinik und Rechtsmedizin. Rechtsmedizin 15 (2005) 10-17
5. Lorenz W., Dick W., Junginger T., Ohmann C., Ennis M., Immich H., et al. Induction of anaesthesia and perioperative risk: influence of antihistamine H1 + H2-prophylaxis and volume substitution with haemaccel-35 on cardiovascular and respiratory disturbances and histamine release. Theor. Surg. 3 (1988) 55-77
6. Pilz G., Fateh-Moghadam S., Viell B., Bujdoso O., Döring G., Marget W., et al. Supplemental immunoglobulin therapy in sepsis and septic shock-comparison of mortality under treatment with polyvalent i.v. immunoglobulin versus placebo. Protocol of a multicenter, randomized, prospective, double-blind trial. Theor. Surg. 8 2 (1993) 61-83
7. Moher D., Schulz K.F., and Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 9281 (2001) 1191-1194
8. R.H. Fletcher, S.W. Fletcher, E.H. Wagner, Clinical epidemiology. The essentials, 3rd ed. Deutschsprach. Ausg. ed. Baltimore: Williams & Wilkins; 1999.
9. Friedman L.M., Furberg C.D., and DeMets D.L. Fundamentals of Clinical Trials (1982), John Wright-PSG Inc., Boston/Bristol/London
10. Pocock S.J. Clinical Trials: A Practical Approach (1983), Hohn Wiley & Sons Ltd., Chichester, New York
11. Altmann D.G., Gore S.M., Gardner M.J., and Pocock S.J. Statistical guidelines for contributors to medical journals. BMJ 286 (1983) 1489-1493
12. Abel U., and Koch A. The mythology of randomization. In: Abel U., and Koch A. (Eds). Nonrandomized Comparative Clinical Studies (1998), Symposion Publishing, Düsseldorf 27-40
13. Lorenz W., Ohmann C., Immich H., Schreiber H.L., Scheibe O., Herfarth C., et al. Patientenzuteilung bei kontrollierten klinischen Studien. Bericht und Empfehlungen von der 2. Arbeitstagung der CAS, 6-7 November 1981 in Marburg/Lahn. Chirurg 53 (1982) 514-519
14. Abel U., and Koch A. The role of randomization in clinical studies: myths and beliefs. J. Clin. Epidemiol. 52 (1999) 487-497
15. Jenicek M. Epidemiology. The Logic of Modern Medicine (1995), Epimed, Montreal
16. Silló-Seidl G. Die Affaire Semmelweis (1985), Herold, Wien München
17. Feinstein A.R., Walter S.D., and Horwitz R.I. An analysis of Berkson's bias in case-control studies. J. Chron. Dis. 39 (1986) 495-504
18. Ennis M., Sangmeister M., Neugebauer E., Knaepler H., Fischer M., Dietz W., et al. Plasma histamine levels in polytraumatized patients. Agents Actions 30 1-2 (1990) 271-273
19. Lunn J.N., and Devlin H.B. Lessons from the confidential enquiry into perioperative deaths in three NHS regions. Lancet 2 8572 (1987) 1384-1386
20. Jennett B. High Technology Medicine. Benefits and Burdens (1986), Oxford University Press, Oxford
21. Kuhn T.S. The Structure of Scientific Revolutions (1962), University of Chicago Press, Chicago
22. Frosch D.L., and Kaplan R.M. Shared decision making in clinical medicine: past research and future directions. Am. J. Prev. Med. 17 (1999) 285-294
23. Koller M., Lorenz W., Wagner K., Keil A., Trott D., Engenhart-Cabillic R., et al. Expectations and quality of life of cancer patients undergoing radiotherapy. J. R. Soc. Med. 93 (2000) 621-628
24. Koller M., Schmitz G., Becker K., Lorenz W., and Engenhart-Cabillic R. Welche Art von Information brauchen Krebspatienten? Patientenaufklärung und das Erleben der Strahlentherapie. In: Bartsch H.H., and Weis J. (Eds). Gemeinsame Entscheidung in der Krebstherapie (2004), Karger, Basel 46-57
25. Koller M., Lorenz W., and Abel U. Methodenvielfalt in der klinischen Forschung: Die Bewertung des Gesamtnutzens für den Patienten braucht mehr als die randomisierte Studie. Münch. Med. Wochenschr. (2006) 85-91
26. Altman D. Practical Statistics for Medical Research (1991), Chapman & Hall, London
27. Green S.B., and Byar D.P. Using observational data from registries to compare treatments: the fallacy of omnimetrics. Stat. Med. 3 (1984) 361-370
28. Trampisch H.J., Windeler J., Ehle B., and Lange S. Medizinische Statistik (1997), Springer, Berlin
29. Sackett D.L., and Wennberg J.E. Choosing the best research design for each question. It's time to stop squabbling over the best methods. BMJ 315 (1997) 1636
30. Bowling A. Measuring disease. A Review of Disease-Specific Quality of Life Measurement Scales. second ed. (2001), Open University Press, Buckingham
31. Schumacher J., Klaiberg A., and Brähler E. Diagnostische Verfahren zu Lebensqualität und Wohlbefinden (2003), Hogrefe, Göttingen
32. Koller M., and Lorenz W. Quality of life: a deconstruction for clinicians. J. R. Soc. Med. 95 (2002) 481-488
33. Nies C., Celik I., Lorenz W., Koller M., Plaul U., Krack W., et al. Outcome nach minimal-invasiver Chirurgie. Qualitative Analyse und Bewertung der klinischen Relevanz von Studienendpunkten durch Patient und Arzt. Chirurg 72 (2001) 19-29
34. Bauhofer A., Lorenz W., Stinner B., Rothmund M., Koller M., Sitter H., et al. Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol of a controlled clinical trial developed by concensus of an international study group. Part two: design of the study. Inflamm. Res. 50 (2001) 187-205
35. Klinkhammer-Schalke M., Koller M., Lorenz W., Jakob C., Steinger B., and Hofstädter F. Implementing a system for diagnosis and treatment of quality of life in breast-cancer patients: concept and a multifaceted approach. J. Cancer Res. Clin. Oncol. 130 Suppl. 1 (2004) 180-181
36. Sackett D.L., Richardson W.S., Rosenberg W., and Haynes R.B. Evidence-based Medicine. How to Practice and Teach EBM (1997), Churchill Livingstone, New York
37. Hamm R.M. Clinical intuition and clinical analysis: expertise and the cognitive continuum. In: Dowie J., and Elstein A. (Eds). Professional Judgement: A Reader in Clinical Decision Making (1988), Cambridge University Press, Cambridge 78-105
38. GRADE Working Group. Grading quality of evicence and strength of recommendations. BMJ 328 (2004) 1490-1498
39. Field M.J., and Lohr K.N. Clinical Practice Guidelines-Directions For A New Program (1990), National Academy Press, Washington
40. W. Lorenz, G. Ollenschläger, M. Geraedts, A. Gandjour, A. Helou, H. Kirchner, et al., Das Leitlinien-Manual von AWMF und ÄZQ, Suppl. 1, ZaeFQ, 2001.
41. Koller M. Beiträge der Sozialpsychologie zur Analyse und Lösung von Problemen im deutschen Gesundheitssystem: Das Beispiel Leitlinien. Z. Sozialpsychol. 36 (2005) 47-60
42. Gross P.A., Greenfield S., Cretin S., Ferguson J., Grimshaw J., Grol R., et al. Optimal methods for guideline implementation: conclusions from Leeds Castle meeting. Med. Care. 39 8 Suppl. II (2001) 85-92